The age-adjusted incidence of chronic lymphocytic leukemia is 4.7 per 100,000 individuals in the United States. Chronic lymphocytic leukemia is a disease of the elderly and is rarely encountered in individuals under the age of 40 years. Most patients who are newly diagnosed with chronic lymphocytic leukemia are over the age 50 years. Males are more commonly affected with chronic lymphocytic leukemia than females. The number of deaths from chronic lymphocytic leukemia is 1.3 per 100,000 individuals in the United States.
The prevalence of chronic lymphocytic leukemia ranges from a low of 10 to 50 cases per 100,000 individuals, with an average prevalence of 30 per 100,000 individuals.
The incidence of chronic lymphocytic leukemia in developed countries is 4 per 100,000 individuals. It increases to more than 30 per 100,000 individuals at the age of 80 years.[1]
In 2011, the age-adjusted incidence of chronic lymphocytic leukemia was 4.82 per 100,000 individuals in the United States.[2]
Thereafter, the incidence of chronic lymphocytic leukemia increases with age.[3]
Chronic lymphocytic leukemia is a disease of the elderly and is rarely encountered among individuals under the age of 40 years.
Most patients who are newly diagnosed with chronic lymphocytic leukemia are over the age 50.
While the overall age-adjusted incidence of chronic lymphocytic leukemia in the United States is 4.4 per 100,000, the age-adjusted incidence of chronic lymphocytic leukemia by age category is:[2]
1.4 per 100,000 individuals among individuals younger than 65 years of age.
25.2 per 100,000 individuals among individuals older than 65 years of age.
Chronic lymphocytic leukemia usually affects individuals of the Caucasian race. African American individuals are slightly less likely to develop chronic lymphocytic leukemia.[5]
Chronic lymphocytic leukemia epidemiology summary[5]Chronic lymphocytic leukemia survival rate[5]Chronic lymphocytic leukemia mortality rate according to age group[5]Chronic lymphocytic leukemia mortality rate according to gender and race[5]Chronic lymphocytic leukemia incidence rate according to age group[5]Chronic lymphocytic leukemia incidence rate according to gender and race[5]Chronic lymphocytic leukemia incidence and mortality relative to all cancer cases in the United States[5]Chronic lymphocytic leukemia incidence and mortality between years 1975 and 2011[5]
↑Yamamoto JF, Goodman MT (May 2008). "Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002". Cancer Causes Control. 19 (4): 379–90. doi:10.1007/s10552-007-9097-2. PMID18064533.
↑ 2.02.12.2Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
↑Yamamoto JF, Goodman MT (May 2008). "Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002". Cancer Causes Control. 19 (4): 379–90. doi:10.1007/s10552-007-9097-2. PMID18064533.
↑Yamamoto JF, Goodman MT (May 2008). "Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002". Cancer Causes Control. 19 (4): 379–90. doi:10.1007/s10552-007-9097-2. PMID18064533.